Bioceramics Market (2026 - 2033)

Bioceramics Market Summary

The global bioceramics market size was valued at USD 8.8 billion in 2025 and is projected to grow from USD 9.4 billion in 2026 to USD 15.1 billion by 2033, at a CAGR of 7.0% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 36.0% in 2025. The rising incidence of musculoskeletal conditions, including osteoporosis, osteoarthritis, and rheumatoid arthritis, among the senior population is expected to fuel market growth. Bioceramics are biocompatible materials that are well tolerated by the human body and are widely used in medical applications owing to their excellent bioactivity, chemical stability, and mechanical properties. They are extensively used in orthopedic load-bearing coatings, dental implants, bone graft substitutes, and bone cement for a wide range of surgical and reconstructive procedures.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Advancements in medical technology have led to an increase in spinal and orthopedic surgeries. Bioceramics are extensively used in spinal fusion, joint replacements, and bone grafts. They are also used for hard tissue (bones) and soft tissue (skin, cartilage) repair for aging populations and trauma-related injuries. Hence, ongoing innovations in tissue engineering and regenerative medicine are expected to contribute to market growth. For instance, in May 2024, CGbio announced positive clinical outcomes for Novosis, a recombinant bone graft material incorporating bioceramic technology for spinal fusion surgery.

Another major factor driving market growth is changing dietary habits and inadequate nutrition, which contribute to the rising prevalence of dental caries and other oral health disorders. Dental procedures, including restorative, cosmetic, and implant treatments, are increasing the demand for bioceramics used in crowns, bridges, dental implants, and bone graft materials. However, ensuring the long-term durability and clinical performance of bioceramic implants remains essential to minimizing implant failure, revision surgeries, and associated healthcare costs. In addition, the high manufacturing costs of bioceramic implants and stringent regulatory requirements continue to pose challenges for manufacturers seeking to balance product performance, quality, and affordability.

Analyst Perspective

The bioceramics market is expected to sustain growth as advancements in biomaterials continue to enhance the performance and longevity of medical implants. Demand is increasingly shifting toward high-performance bioceramics that offer superior biocompatibility, mechanical strength, and wear resistance for orthopedic, dental, and spinal applications. Ongoing research in regenerative medicine and tissue engineering is expanding the scope of bioceramic materials beyond conventional implant applications, creating new opportunities for product innovation. At the same time, manufacturers are investing in advanced processing technologies and material development to improve clinical outcomes and address evolving healthcare requirements. Although high production costs and stringent regulatory pathways remain key challenges, continuous innovation, increasing surgical procedure volumes, and expanding healthcare infrastructure are expected to support the long-term commercial growth of the global bioceramics market.

Material Insights

By material, alumina-based bioceramics accounted for over 63.0% in 2025, owing to their excellent biocompatibility, which is increasingly well accepted by the human body during implantation. The material's strength and wear resistance are ideal for load-bearing applications, including joint replacements and orthopedic implants. In addition, alumina remains stable across various physiological environments, minimizing adverse reactions and ensuring long-term performance. For instance, in October 2025, KYOCERA Fineceramics Medical GmbH announced commercial production of BIOCERAM AZUL, a zirconia-toughened alumina (ZTA) bioceramic for hip endoprosthetic applications. The material offers high fracture toughness, wear resistance, and biocompatibility for orthopedic implants, supporting growing demand for advanced alumina-based bioceramics in joint replacement procedures. It is corrosion-resistant, which ensures durability and longevity in medical applications. Alumina-based bioceramics also exhibit excellent corrosion resistance and long-term dimensional stability, making them suitable for demanding orthopedic and dental implant applications where durability and wear performance are critical.

Zirconia-based bioceramics are expected to grow at the fastest CAGR during the forecast period, owing to their biocompatibility, high strength, and fracture toughness. The rising senior population has increased demand for joint replacements and dental procedures, boosting demand for zirconia bioceramics. Zirconia-based hip and knee implants have gained significant popularity due to wear-resistant performance and reduced risk of adverse conditions, including the need for frequent replacements. In addition, this material is widely used in dentistry for crowns, bridges, and dental implants owing to its natural appearance and durability.

Application Insights

By application, dental applications held the largest market share, exceeding 40.0% in 2025, driven by the growing prevalence of dental ailments, including cavities, tooth decay, and gum diseases. Bioceramics are popular in such treatments, with applications in dental crowns, bridges, and implants. Furthermore, technological advancements improve dental implant procedures, making bioceramics more effective and reliable.

Orthopedic applications are projected to witness substantial growth during the forecast period, due to the rising incidence of degenerative joint diseases and musculoskeletal disorders. According to a 2025 scoping review published in the Journal of Clinical Medicine CERAMENT, a synthetic bone substitute composed of calcium sulfate and hydroxyapatite, across multiple orthopedic applications. The review evaluated findings from 22 clinical studies, highlighting the growing clinical adoption of bioceramic materials in orthopedic procedures. Bioceramic materials are increasingly used in orthopedic implants for their bioactivity, biocompatibility, and ability to support bone regeneration, thereby contributing to improved clinical outcomes in knee, hip, and shoulder replacement procedures. In addition, the growing geriatric population is increasing demand for orthopedic biomaterials used in joint replacement and bone repair procedures.

Regional Insights

The North America bioceramics market secured the dominant share of approximately 36.0% in 2025, owing to its advanced healthcare infrastructure, well-established research ecosystem, and increasing adoption of bioceramic materials across orthopedic, dental, and regenerative medicine applications. High healthcare expenditure, strong medical device innovation, and stringent regulatory standards have supported the commercialization and clinical adoption of advanced bioceramic products in the region. In addition, the growing older population and rising prevalence of musculoskeletal disorders and dental conditions continue to drive demand for joint replacement procedures, dental implants, and bone graft materials, further supporting market growth.

To learn more about this report, Download Free Sample Report

U.S. Bioceramics Market Trends

The rising demand for bioceramics in medical applications, including orthopedics, tissue engineering, and restorative dentistry, has further supported market growth in the U.S. The country continues to witness increasing volumes of hip, knee, and dental implant procedures, in which bioceramic materials are widely used for their biocompatibility, bioactivity, wear resistance, and long-term clinical performance. 

Europe Bioceramics Market Trends

The bioceramics market in Europe accounted for a significant share in 2025, supported by the region's growing aging population and increasing prevalence of orthopedic and dental disorders. Rising healthcare expenditure across countries such as Germany, the UK, France, Italy, and Denmark has further increased the adoption of advanced bioceramic materials. Europe also maintains a strong manufacturing and research base for bioceramics used in orthopedic, dental, and other hard tissue replacement applications. For instance, in October 2025, KYOCERA Fineceramics Medical GmbH opened a new production facility in Waiblingen, Germany, dedicated to manufacturing high-performance BIOCERAM AZUL ceramic components for hip implants and other orthopedic applications.

Asia Pacific Bioceramics Market Trends

The Asia-Pacific bioceramics market is expected to grow during the forecast period. Factors driving this growth include an expanding population and robust economic development, which are leading to increased healthcare needs. Improved healthcare infrastructure, especially in countries such as China and India, has facilitated the adoption of advanced medical technologies, including bioceramics applications. Additionally, ongoing technological advancements and government initiatives to enhance healthcare access have further propelled market expansion.

Key Bioceramics Company Insights

The bioceramics market is moderately consolidated, with leading companies focusing on product innovation, strategic collaborations, manufacturing expansion, and research and development activities to enhance mechanical performance, bioactivity, and clinical applications of bioceramic materials. Manufacturers are also expanding their product portfolios to address the growing demand from orthopedic, dental, and regenerative medicine applications.

Key Bioceramics Companies

The following key companies have been profiled for this study on the bioceramics market:

• BONE SUPPORT AB

• CeramTec GmbH

• Carborundum Universal Limited

• CoorsTek, Inc.

• Jyoti Ceramic Industries Pvt. Ltd.

• Kyocera Corporation

• Morgan Advanced Materials plc

• Nobel Biocare Holding AG

• Sagemax Bioceramics, Inc.

• Tosoh Corporation

• Zimmer Biomet Holdings, Inc.

Recent Developments

• In May 2026, Kettenbach Dental launched the VISALYS BioCeramic Block, a CAD/CAM bioceramic material for permanent dental restorations. The material features a biomimetic structure inspired by natural dentin and enamel, providing strength, elasticity, aesthetics, and balanced force distribution for restorative dental applications.

• In May 2026, Himed, a manufacturer of calcium phosphate bioceramic materials, partnered with Adva Cera to establish an end-to-end development and production platform for 3D-printed bioceramic implants for dental, orthopedic, and spinal applications.

• In May 2024, Himed and Lithoz established the Bioceramics Center of Excellence to support research, design optimization, and commercialization of advanced bioceramic implants. The center enables medical device developers to optimize calcium phosphate and beta-tricalcium phosphate implant designs before commercial-scale manufacturing.

Global Bioceramics Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each sub segment from 2021 to 2033. For this study, Grand View Research has segmented the global bioceramics market report on the basis of material, application, and region.

• Material Outlook (Revenue, USD Billion, 2021 - 2033)

  • Alumina

  • Zirconia

  • Others

• Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Dental

  • Orthopedic

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia & New Zealand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • UAE

    • Saudi Arabia

    • South Africa